Victoria A. Joshi

4.2k citations

29 papers · 3.0k indexed · 1 hit paper · h-index 17

Pulmonary and Respiratory Medicine top 1%
Oncology top 1%
Molecular Biology top 10%
Cancer Research top 5%
Immunology top 10%

Co-authors: Pasi A. Jänne Lecia V. Sequist Bruce E. Johnson Neal I. Lindeman Thomas J. Lynch Daniel A. Haber Matthew Meyerson Alona Muzikansky
Topics: Lung Cancer Treatments and Mutations (18 papers)Cancer Genomics and Diagnostics (11 papers)Lung Cancer Research Studies (9 papers)
Cited by: Oncology Pulmonary and Respiratory Medicine Cancer Research
Journals: Nature Genetics Journal of Clinical Oncology Gastroenterology
Partner nations: United States Canada Australia

In The Last Decade

Victoria A. Joshi

29 papers receiving 3.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

First-Line Gefitinib in Patients With Advanced Non–Small-Cell Lung Cancer Harboring SomaticEGFRMutations

2008 661 citations Lecia V. Sequist, Pasi A. Jänne et al. Journal of Clinical Oncology profile →

Peers

Countries citing papers authored by Victoria A. Joshi

Since Specialization

Citations

This map shows the geographic impact of Victoria A. Joshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Victoria A. Joshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Victoria A. Joshi more than expected).

Fields of papers citing papers by Victoria A. Joshi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Victoria A. Joshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Victoria A. Joshi. The network helps show where Victoria A. Joshi may publish in the future.

Co-authorship network of co-authors of Victoria A. Joshi

This figure shows the co-authorship network connecting the top 25 collaborators of Victoria A. Joshi. A scholar is included among the top collaborators of Victoria A. Joshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Victoria A. Joshi. Victoria A. Joshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Assessing Chilli Genotypes: A Study of Morphological and Nutritional Traits 2024 ·Asian Journal of Research in Biochemistry ·Jayesh Patel,(unknown),(unknown),(unknown),(unknown),Victoria A. Joshi,(unknown)	1
2	GermlineTP53Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry 2015 ·JAMA Oncology ·Matthew B. Yurgelun,Serena Masciari,Victoria A. Joshi,Rowena Mercado,Noralane M. Lindor,Steven Gallinger,John L. Hopper,Mark A. Jenkins,Daniel D. Buchanan,Polly A. Newcomb,John D. Potter,Robert W. Haile,Raju Kucherlapati,Sapna Syngal	65
3	The spectrum of FBN1, TGFβR1, TGFβR2 and ACTA2 variants in 594 individuals with suspected Marfan Syndrome, Loeys–Dietz Syndrome or Thoracic Aortic Aneurysms and Dissections (TAAD) 2014 ·Molecular Genetics and Metabolism ·Jordan Lerner‐Ellis,Saud H. AlDubayan,(unknown),Melissa Kelly,Aaron J. Stuenkel,Jennifer Walsh,Victoria A. Joshi	36
4	The Introduction of Systematic Genomic Testing for Patients with Non–Small-Cell Lung Cancer 2012 ·Journal of Thoracic Oncology ·Stephanie Cardarella,Taylor M. Ortiz,Victoria A. Joshi,Mohit Butaney,David M. Jackman,David J. Kwiatkowski,Beow Y. Yeap,Pasi A. Jänne,Neal I. Lindeman,Bruce E. Johnson	77
5	The Creating an Optimal Warfarin Nomogram (CROWN) Study 2011 ·Thrombosis and Haemostasis ·Todd S. Perlstein,Samuel Z. Goldhaber,Kerrie P. Nelson,Victoria A. Joshi,Todd M. Morgan,Lawrence J. Lesko,Jooyeon Lee,Jogarao Gobburu,David Schoenfeld,Raju Kucherlapati,Mason W. Freeman,Mark A. Creager	11
6	The GeneInsight suite: a platform to support laboratory and provider use of DNA-based genetic testing 2011 ·Human Mutation ·Samuel Aronson,Eugene Clark,Lawrence Babb,Samantha Baxter,Lisa Farwell,Birgit Funke,(unknown),Victoria A. Joshi,Elaine Lyon,(unknown),(unknown),Matthew Varugheese,(unknown),Heidi L. Rehm	53
7	The introduction of systematic genomic testing for patients with non-small cell lung cancer (NSCLC) at Dana-Farber Cancer Institute (DFCI). 2011 ·Journal of Clinical Oncology ·Taylor M. Ortiz,Victoria A. Joshi,(unknown),Mohit Butaney,(unknown),D. M. Jackman,D J Kwiatkowski,(unknown),Pasi A. Jänne,B. E. Johnson	4
8	EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer 2010 ·Neuro-Oncology ·April F. Eichler,Kristopher T. Kahle,(unknown),Victoria A. Joshi,Henning Willers,J. A. Engelman,Thomas J. Lynch,Lecia V. Sequist	213
9	EGFRMutation Is a Better Predictor of Response to Tyrosine Kinase Inhibitors in Non–Small Cell Lung Carcinoma Than FISH, CISH, and Immunohistochemistry 2010 ·American Journal of Clinical Pathology ·Lynette M. Sholl,Yun Xiao,Victoria A. Joshi,Beow Y. Yeap,Leigh‐Anne Cioffredi,David M. Jackman,Charles Lee,Pasi A. Jänne,Neal I. Lindeman	86
10	DNA Sequencing of Cancer-Related Genes for Biomarker Discovery 2009 ·Methods in molecular biology ·Lisa Farwell,Victoria A. Joshi	2
11	EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer 2009 ·Cancer Cytopathology ·(unknown),Edmund S. Cibas,Pasi A. Jänne,Victoria A. Joshi,Kelly H. Zou,Neal I. Lindeman	136
12	Platform Evaluation for Rapid Genotyping of CYP2C9 and VKORC1 Alleles 2009 ·Personalized Medicine ·Victoria A. Joshi,Elizabeth Hynes,Birgit Funke,Lisa Farwell,Debora Mancini‐DiNardo,Raju Kucherlapati	1
13	Genetics and Genomics in the Practice of Medicine 2008 ·Gastroenterology ·Victoria A. Joshi,Raju Kucherlapati	2
14	Selection of a Platform for Mutation Detection 2008 ·Current Protocols in Human Genetics ·Victoria A. Joshi,Debora Mancini‐DiNardo,Birgit Funke	4
15	Mucinous Differentiation Correlates with Absence of EGFR Mutation and Presence of KRAS Mutation in Lung Adenocarcinomas with Bronchioloalveolar Features 2007 ·Journal of Molecular Diagnostics ·Karin E. Finberg,Lecia V. Sequist,Victoria A. Joshi,Alona Muzikansky,Julie M. Miller,Moonjoo Han,Javad Beheshti,Lucian R. Chirieac,Eugene J. Mark,A. John Iafrate	158
16	Exon 19 Deletion Mutations of Epidermal Growth Factor Receptor Are Associated with Prolonged Survival in Non–Small Cell Lung Cancer Patients Treated with Gefitinib or Erlotinib 2006 ·Clinical Cancer Research ·David M. Jackman,Beow Y. Yeap,Lecia V. Sequist,Neal I. Lindeman,Alison J. Holmes,Victoria A. Joshi,Daphne W. Bell,Mark S. Huberman,Balázs Halmos,Michael S. Rabin,Daniel A. Haber,Thomas J. Lynch,Matthew Meyerson,Bruce E. Johnson,Pasi A. Jänne	491
17	Germline gain-of-function mutations in SOS1 cause Noonan syndrome 2006 ·Nature Genetics ·Amy E. Roberts,Toshiyuki Araki,Kenneth D. Swanson,Kate Montgomery,Taryn A. Schiripo,Victoria A. Joshi,Li Li,Yosuf Yassin,Alex M. Tamburino,Benjamin G. Neel,Raju Kucherlapati	421
18	Lung cancer genetics and pharmacogenomics 2006 ·Cytogenetic and Genome Research ·Victoria A. Joshi,Raju Kucherlapati	2
19	Epidermal Growth Factor ReceptorMutation Testing in the Care of Lung Cancer Patients 2006 ·Clinical Cancer Research ·Lecia V. Sequist,Victoria A. Joshi,Pasi A. Jänne,Daphne W. Bell,Panos Fidias,Neal I. Lindeman,David N. Louis,Jeffrey C. Lee,Eugene J. Mark,Janina Longtine,Peter C. Verlander,Raju Kucherlapati,Matthew Meyerson,Daniel A. Haber,Bruce E. Johnson,Thomas J. Lynch	65
20	A Rapid and Sensitive Enzymatic Method for Epidermal Growth Factor Receptor Mutation Screening 2006 ·Clinical Cancer Research ·Pasi A. Jänne,Ana M. Borras,Yanan Kuang,Andrew M. Rogers,Victoria A. Joshi,(unknown),Neal I. Lindeman,Jeffrey C. Lee,Balázs Halmos,Elizabeth A. Maher,R Distel,Matthew Meyerson,Bruce E. Johnson	183

About Victoria A. Joshi

Victoria A. Joshi is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine, having authored 29 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (18 papers), Cancer Genomics and Diagnostics (11 papers) and Lung Cancer Research Studies (9 papers). The work is most often cited by research in Oncology (1.8k citations), Pulmonary and Respiratory Medicine (2.1k citations) and Cancer Research (638 citations). Victoria A. Joshi has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Pasi A. Jänne, Lecia V. Sequist, Bruce E. Johnson, Neal I. Lindeman, Thomas J. Lynch, Daniel A. Haber, Matthew Meyerson, Alona Muzikansky, Beow Y. Yeap and David M. Jackman. Their work appears in journals such as Nature Genetics, Journal of Clinical Oncology and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact